SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ebola Outbreak 2014 - News, Updates and Related Investments

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: statesidereport who wrote (28)8/1/2014 1:20:30 PM
From: statesidereport  Read Replies (1) of 608
 
Congressional Report: Ebola Bio Kits Deployed to National Guard Units In All 50 States

*****Nothing to worry about*******

Mac Slavo
July 29th, 2014

The Department of Defense informed Congress that it has deployed biological diagnostic systems to National Guard support teams in all 50 states, according to a report published by the Committee on Armed Services. The report, published in April amid growing fears that the Ebola hemorrhagic fever virus might spread outside of West Africa, says that the portable systems are designed for “low probability, high consequence” scenarios.

Some 340 Joint Biological Agent Identification and Diagnostic System (JBAIDS) units have thus far been given to emergency response personnel. The systems are “rapid, reliable, and [provide] simultaneous identification of specific biological agents and pathogens,” says executive officer for the DOD’s Chemical and Biological Defense group Carmen J. Spencer.

The Chemical and Biological Defense Program has sharpened the DoD diagnostics portfolio by increasing the capability of our fielded system, some 340 of which have been provided to the Military Services.

The Joint Biological Agent Identification and Diagnostic System is a portable system capable of rapid, reliable, and simultaneous identification of specific biological agents and pathogens. By partnering with the U.S. Army Medical Research and Materiel Command and the Food and Drug Administration, we have made accessible additional diagnostic assays for high consequence, low probability biological threat agents for use during declared public health emergencies.

This collaboration has facilitated the availability of viral hemorrhagic fever diagnostic assays for use during a declared emergency and adds previously unavailable preparedness capabilities to this fielded system.



To address the need for a near term capability to combat emerging threat materials, we have already provided Domestic Response Capability kits to the National Guard weapons of mass destruction civil support teams resident in all 50 states.

These kits provide emerging threat mitigation capability that includes detection, personnel protection, and decontamination.

Full Congressional Report via POTR
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext